STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Company

NRX Pharmaceuticals, Inc.

Filed

March 17, 2020

Period of Report

March 13, 2020

Accession Number

0001062993-20-001375